Rein Therapeutics Inc.
Rein Therapeutics Inc. (RNTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RNTX · as of Jun 9, 2026
Key Statistics
Explore Rein Therapeutics Inc. Data
rntx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
The RNTX analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing +532.44% upside from the current price of $0.95.
Competitors & Peers
rntx competitorsRNTX
ATNM
BCAB
BEAT
CELU
KZRStock Performance
Full HistoryAbout Rein Therapeutics Inc.
Rein Therapeutics Inc. operates as a clinical-stage biopharmaceutical enterprise focused on discovering and bringing to market novel therapeutic solutions for various conditions, notably cancer. The c…
what is rein therapeutics inc. · rntx stock overview · rein therapeutics inc. company profile · who is rein therapeutics inc. ceo · rntx NASDAQ · rein therapeutics inc. headquarters · rein therapeutics inc. business segments
About Stock Overview & Key Data
Rein Therapeutics Inc. (RNTX) is a Healthcare company in the Medical - Pharmaceuticals industry, listed on NASDAQ since Jun 29, 2017. As of the latest trading session, RNTX stock price is $0.95, with a market capitalization of $26.5M. The stock has returned -52.09% over the past 12 months and -18.22% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Rein Therapeutics Inc. stock is Buy, with an average 12-month price target of $6.00. In fiscal year 2025, Rein Therapeutics Inc. reported revenue of — and net income of -$49.9M. For detailed data — including Rein Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Rein Therapeutics Inc. (RNTX) stock price is $0.95. The stock is traded on NASDAQ under the ticker symbol RNTX. The 52-week range is $0.92 – $2.18.